Catherine Mackey is listed as a director on 2 SEC Form D filings by 1 issuer between Mar 2023 and Jan 2024: Voyager Therapeutics, Inc. (Lexington, MA — biotechnology — 2023–2024; $60M reported sold to 10 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Alfred Sandrock (2 shared filings), Glenn Pierce (2 shared filings), Grace Colon (2 shared filings), James Geraghty (2 shared filings), Jude Onyia (2 shared filings) and 9 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Catherine. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 7 bankruptcy cases matching the name listed in Key records below.
What this means 7 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Catherine Mackey and found 4 differences: Same name, different state: "Catherine J. Mackey" (CA) is a separate record; Same name, different state: "Catherine Mackey" (IL) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.